Psychemedics (PMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,527 | 2,969 | 4,484 | 4,902 | 4,049 |
| Depreciation Amortization | 337 | 331 | 347 | 287 | 409 |
| Income taxes - deferred | 130 | -72 | -65 | 170 | -70 |
| Accounts receivable | 382 | 157 | -359 | 76 | 18 |
| Accounts payable and accrued liabilities | -464 | 156 | -11 | 132 | -187 |
| Other Working Capital | 65 | -65 | -114 | -848 | -73 |
| Other Operating Activity | 422 | 212 | 608 | -114 | 169 |
| Operating Cash Flow | $2,400 | $3,688 | $4,891 | $4,605 | $4,315 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,006 | 3,875 | -192 | -1,133 | -2,550 |
| PPE Investments | -35 | -345 | -416 | -257 | -289 |
| Purchase Of Investment | -15 | -18 | -19 | N/A | 4 |
| Investing Cash Flow | $-1,056 | $3,513 | $-627 | $-1,390 | $-2,835 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | -79 | -810 | -41 | N/A | N/A |
| Dividend Paid | -3,014 | -6,056 | -2,999 | -2,456 | -1,857 |
| Other Financing Activity | -39 | 199 | 692 | 69 | 469 |
| Financing Cash Flow | $-3,133 | $-6,667 | $-2,348 | $-2,387 | $-1,388 |
| Beginning Cash Position | 6,630 | 6,097 | 4,180 | 3,353 | 3,260 |
| End Cash Position | 4,840 | 6,630 | 6,097 | 4,180 | 3,353 |
| Net Cash Flow | $-1,790 | $533 | $1,917 | $828 | $92 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,400 | 3,688 | 4,891 | 4,605 | 4,315 |
| Capital Expenditure | -35 | -345 | -416 | -257 | -289 |
| Free Cash Flow | 2,364 | 3,343 | 4,475 | 4,348 | 4,026 |